![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
PubChem CID | |
Chemical and physical data | |
Formula | C16H23NO2 |
Molar mass | 261.365 g·mol−1 |
3D model (JSmol) | |
| |
|
MXiPr (Methoxisopropamine, Isopropyloxetamine) is a recreational designer drug with dissociative effects. It is an arylcyclohexylamine derivative, related to drugs such as ketamine and methoxetamine. It was first identified in Slovenia in December 2020,[1] and was made illegal in Hungary in April 2021.[2]
See also
References
- ^ "Analytical Report for MXiPr" (PDF). National Forensic Laboratory, Police, Ministry of the Interior. Republic of Slovenia.
(2‐(3‐methoxyphenyl)‐2‐[(propan‐2‐yl)amino]cyclohexan‐1‐one C16H23NO2)
- ^ "Amendment of Decree No 55/2014 of 30 December 2014 on substances or groups of compounds classified as new psychoactive substances". Minister for Human Capacities. Government of Hungary. 2021/225/HU.
|
σ1 |
|
---|---|
σ2 | |
Unsorted |
|
See also: Receptor/signaling modulators |